LncPRYP4-3 serves as a novel diagnostic biomarker for dissecting subtypes of metabolic associated fatty liver disease by targeting RPS4Y2

作者：Hongju Yang, Qian Li, Leisheng Zhang, Mei Zhu, Jie Niu, Fenglin Xue, Lihong Yang, Qiu Qu, Yaling Lao, Zheng Ding, Changyan Xiao, Kunhua Wang · 发表于：Clinical and Experimental Medicine · 年份：2020 · DOI：10.1007/s10238-020-00636-1 · 被引用次数：23 · 研究领域：Liver Disease Diagnosis and Treatment、Cancer-related molecular mechanisms research、Lipid metabolism and disorders